-
srdr.ahrq.gov/projects/1708/studies/197323
January 01, 2007 - Description
Impact of continuous low level heatwrap therapy in acute low back pain patients: subjective and objective … Impact of continuous low level heatwrap therapy in acute low back pain patients: subjective and objective
-
srdr.ahrq.gov/projects/592/studies/81975
January 01, 2007 - Impact of continuous low level heatwrap therapy in acute low back pain patients: subjective and objective … Impact of continuous low level heatwrap therapy in acute low back pain patients: subjective and objective
-
srdr.ahrq.gov/projects/1634
Methodology
We will use the ("Metaprop") package in R in order to integrate the results pertaining to the Objective … Post/View
Key Questions
1
What are the Objective
-
srdr.ahrq.gov/projects/1634/studies/193574
January 01, 2019 - Key Questions Addressed
1
What are the Objective response rates (ORR), Complete remission
-
srdr.ahrq.gov/projects/1634/studies/193577
January 01, 2019 - Key Questions Addressed
1
What are the Objective response rates (ORR), Complete remission
-
srdr.ahrq.gov/projects/1520/studies/186172
January 01, 2018 - High
no blinding
Comments ( 0 ) |
Post/View
Q18: Cochrane - FOR OBJECTIVE OUTCOMES - Blinding … methods used to guide physical examination and validity of assessment for rebound tenderness or more objective
-
srdr.ahrq.gov/projects/1634/studies/193576
January 01, 2017 - Description
Enasidenib in mutant
Key Questions Addressed
1
What are the Objective
-
srdr.ahrq.gov/projects/1542/studies/198915
Comments ( 0 ) |
Post/View
Q18: Cochrane - FOR OBJECTIVE OUTCOMES -
-
srdr.ahrq.gov/home/index
December 13, 2021 - 1 Extraction Form,
Date Created: Jan 09, 2021 12:16AM
Description: Objective
-
srdr.ahrq.gov/
December 13, 2021 - 1 Extraction Form,
Date Created: Jan 09, 2021 12:16AM
Description: Objective
-
srdr.ahrq.gov/projects/1520/studies/197239
January 01, 2020 - No
Comments ( 0 ) |
Post/View
Q18: Cochrane - FOR OBJECTIVE OUTCOMES - Blinding of outcome
-
srdr.ahrq.gov/projects/1520/studies/186754
January 01, 2019 - Comments ( 0 ) |
Post/View
Q18: Cochrane - FOR OBJECTIVE OUTCOMES - Blinding of outcome assessor
-
srdr.ahrq.gov/projects/1634/studies/193578
January 01, 2018 - Key Questions Addressed
1
What are the Objective response rates (ORR), Complete remission
-
srdr.ahrq.gov/projects/1520/studies/186845
January 01, 2014 - Comments ( 0 ) |
Post/View
Q18: Cochrane - FOR OBJECTIVE OUTCOMES - Blinding of outcome assessor
-
srdr.ahrq.gov/projects/1520/studies/186755
January 01, 2015 - Comments ( 0 ) |
Post/View
Q18: Cochrane - FOR OBJECTIVE OUTCOMES - Blinding of outcome assessor
-
srdr.ahrq.gov/projects/1520/studies/186756
January 01, 2002 - Comments ( 0 ) |
Post/View
Q18: Cochrane - FOR OBJECTIVE OUTCOMES - Blinding of outcome assessor
-
srdr.ahrq.gov/projects/1520/studies/186817
January 01, 2007 - High
Comments ( 0 ) |
Post/View
Q18: Cochrane - FOR OBJECTIVE OUTCOMES - Blinding of outcome
-
srdr.ahrq.gov/projects/1520/studies/197240
January 01, 2020 - Comments ( 0 ) |
Post/View
Q18: Cochrane - FOR OBJECTIVE OUTCOMES - Blinding of outcome assessor
-
srdr.ahrq.gov/projects/1520/studies/186810
January 01, 2019 - Comments ( 0 ) |
Post/View
Q18: Cochrane - FOR OBJECTIVE OUTCOMES - Blinding of outcome assessor
-
srdr.ahrq.gov/projects/1520/studies/186178
January 01, 2019 - Comments ( 0 ) |
Post/View
Q18: Cochrane - FOR OBJECTIVE OUTCOMES - Blinding of outcome assessor